UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancers: An NRG Oncology/Gynecologic Oncology Group study

Gynecologic oncology, 2017-11, Vol.147 (2), p.283-290

2017

Volltextzugriff (PDF)

Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2015-09, Vol.26, p.v40-v55

2015

Volltextzugriff (PDF)

Systemic treatment for thymic malignancies

Current opinion in oncology, 2017-03, Vol.29 (2), p.112-117

2017

Volltextzugriff (PDF)

Trends in the receipt of guideline care and survival for women with ovarian cancer: A population-based study

Gynecologic oncology, 2017-06, Vol.145 (3), p.486-492

2017

Volltextzugriff (PDF)

Is perioperative visual estimation of intra-abdominal tumor spread reliable in ovarian cancer surgery after neoadjuvant chemotherapy?

Gynecologic oncology, 2013-02, Vol.128 (2), p.229-232

2013

Volltextzugriff (PDF)

A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer

Gynecologic oncology, 2015-01, Vol.136 (1), p.130-135

2015

Volltextzugriff (PDF)

Ovarian cancer: strategies for overcoming resistance to chemotherapy

Nature reviews. Cancer, 2003-07, Vol.3 (7), p.502-516

2003

Volltextzugriff (PDF)

Surgical readmission and survival in women with ovarian cancer: Are short-term quality metrics incentivizing decreased long-term survival?

Gynecologic oncology, 2017-12, Vol.147 (3), p.607-611

2017

Volltextzugriff (PDF)

Cytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study

Annals of surgical oncology, 2015-05, Vol.22 (5), p.1570-1575

2015

Volltextzugriff (PDF)

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2013-10, Vol.24 Suppl 6, p.vi24-vi32

2013

Volltextzugriff (PDF)

Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery

Gynecologic oncology, 2013-12, Vol.131 (3), p.531-534

2013

Volltextzugriff (PDF)

Ovarian cancer stem cells more questions than answers

Seminars in cancer biology, 2017-06, Vol.44, p.67-71

Ottevanger, P.B

2017

Volltextzugriff (PDF)

Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis

American Journal of Physiology: Cell Physiology, 2015-10, Vol.309 (7), p.C444-C456

2015

Volltextzugriff (PDF)

Prognostic value of miliary versus non-miliary sub-staging in advanced ovarian cancer

Gynecologic oncology, 2017-07, Vol.146 (1), p.52-57

2017

Volltextzugriff (PDF)

Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer

Gynecologic oncology, 2016-08, Vol.142 (2), p.237-242

2016

Volltextzugriff (PDF)

Genomics to immunotherapy of ovarian clear cell carcinoma: Unique opportunities for management

Gynecologic oncology, 2018-11, Vol.151 (2), p.381-389

2018

Volltextzugriff (PDF)

Updated treatment recommendations for newly diagnosed epithelial ovarian carcinoma from the ESMO Clinical Practice Guidelines

Annals of oncology, 2021-10, Vol.32 (10), p.1300-1303

2021

Volltextzugriff (PDF)

Reporting ‘Denominator’ data is essential for benchmarking and quality standards in ovarian cancer

Gynecologic oncology, 2017-07, Vol.146 (1), p.94-100

2017

Volltextzugriff (PDF)

Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy

Gynecologic oncology, 2012-05, Vol.125 (2), p.362-366

2012

Volltextzugriff (PDF)

Who are the long-term survivors of high grade serous ovarian cancer?

Gynecologic oncology, 2018-01, Vol.148 (1), p.204-212

2018

Volltextzugriff (PDF)

Recent progress in the diagnosis and treatment of ovarian cancer

CA: a cancer journal for clinicians, 2011-05, Vol.61 (3), p.183-203

2011

Volltextzugriff (PDF)

Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment

International journal of molecular sciences, 2016-12, Vol.17 (12), p.2113-2113

2016

Volltextzugriff (PDF)

Epithelial ovarian cancer

Journal of the National Comprehensive Cancer Network, 2011-01, Vol.9 (1), p.82-113

2011

Volltextzugriff (PDF)

Low-grade serous ovarian cancer: A review

Gynecologic oncology, 2016-11, Vol.143 (2), p.433-438

2016

Volltextzugriff (PDF)

1 – 25 von 2.381

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.140)
Mit Volltextzugriff
(1.972)

Publikationsform

Sprache

13 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(2.349)
Female
(2.081)
Science & Technology
(2.045)
Life Sciences & Biomedicine
(1.985)
Carcinoma, Ovarian Epithelial
(1.446)
Oncology
(1.402)
Neoplasms, Glandular And Epithelial - Drug Therapy
(1.386)
Ovarian Neoplasms - Drug Therapy
(1.252)
Neoplasms, Glandular And Epithelial - Pathology
(1.140)
Middle Aged
(1.113)
Ovarian Cancer
(1.098)
Ovarian Neoplasms - Pathology
(992)
Aged
(944)
Adult
(872)
Obstetrics & Gynecology
(572)
Neoplasms, Glandular And Epithelial - Therapy
(562)
Chemotherapy
(535)
Neoplasm Staging
(518)
Prognosis
(478)
Neoplasms, Glandular And Epithelial - Mortality
(470)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(2.375)
IngentaConnect
(1.266)
EZB Electronic Journals Library
(1.063)
Journals@Ovid
(844)
Elsevier ScienceDirect Journals Collection
(562)
IngentaConnect Journals
(477)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(451)
Publisher or Other Site
(341)
2022 ECC(Springer)
(326)
Wiley Online Library
(299)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(192)
Wiley Online Library Full Collection 2018
(132)
BMJ Journals
(123)
Taylor & Francis Journals
(102)
Taylor & Francis
(99)
Taylor & Francis:Master (3349 titles)
(72)
Nature
(72)
Nexis Uni
(56)
SAGE Publications
(42)
Springer Book Series
(39)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Gynecologic Oncology
(285)
International Journal Of Gynecological Cancer
(108)
Annals Of Oncology
(55)
Journal Of Clinical Oncology
(50)
European Journal Of Gynaecological Oncology
(44)
Oncotarget
(42)
Plos One
(38)
Clinical Cancer Research
(37)
Oncology Reports
(37)
British Journal Of Cancer
(33)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Systemic treatment for thymic malignancies

Trends in the receipt of guideline care and survival for women with ovarian cancer: A population-based study

Is perioperative visual estimation of intra-abdominal tumor spread reliable in ovarian cancer surgery after neoadjuvant chemotherapy?

A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer

Ovarian cancer: strategies for overcoming resistance to chemotherapy

Surgical readmission and survival in women with ovarian cancer: Are short-term quality metrics incentivizing decreased long-term survival?

Cytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery

Ovarian cancer stem cells more questions than answers

Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis

Prognostic value of miliary versus non-miliary sub-staging in advanced ovarian cancer

Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer

Genomics to immunotherapy of ovarian clear cell carcinoma: Unique opportunities for management

Updated treatment recommendations for newly diagnosed epithelial ovarian carcinoma from the ESMO Clinical Practice Guidelines

Reporting ‘Denominator’ data is essential for benchmarking and quality standards in ovarian cancer

Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy

Who are the long-term survivors of high grade serous ovarian cancer?

Recent progress in the diagnosis and treatment of ovarian cancer

Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment

Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial

Epithelial ovarian cancer

Low-grade serous ovarian cancer: A review

Suchergebnisse filtern